Prudential Financial’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.13M Sell
32,125
-18,250
-36% -$1.78M ﹤0.01% 1157
2025
Q1
$5.23M Buy
50,375
+22,410
+80% +$2.33M 0.01% 828
2024
Q4
$2.94M Buy
27,965
+3,574
+15% +$375K ﹤0.01% 1110
2024
Q3
$3.05M Buy
24,391
+15,847
+185% +$1.98M ﹤0.01% 1235
2024
Q2
$1.35M Buy
8,544
+6,387
+296% +$1.01M ﹤0.01% 1667
2024
Q1
$279K Sell
2,157
-196
-8% -$25.4K ﹤0.01% 2364
2023
Q4
$227K Sell
2,353
-10
-0.4% -$964 ﹤0.01% 2399
2023
Q3
$286K Sell
2,363
-100
-4% -$12.1K ﹤0.01% 2277
2023
Q2
$282K Sell
2,463
-16,000
-87% -$1.83M ﹤0.01% 2323
2023
Q1
$2.39M Buy
18,463
+15,200
+466% +$1.97M ﹤0.01% 1224
2022
Q4
$423K Sell
3,263
-19,611
-86% -$2.54M ﹤0.01% 2097
2022
Q3
$2.51M Sell
22,874
-59,100
-72% -$6.48M ﹤0.01% 1201
2022
Q2
$6.32M Sell
81,974
-314,100
-79% -$24.2M 0.01% 821
2022
Q1
$30.9M Buy
396,074
+370,902
+1,473% +$29M 0.04% 374
2021
Q4
$2.27M Buy
25,172
+22,700
+918% +$2.05M ﹤0.01% 1469
2021
Q3
$214K Sell
2,472
-200
-7% -$17.3K ﹤0.01% 2455
2021
Q2
$207K Sell
2,672
-44
-2% -$3.41K ﹤0.01% 2445
2021
Q1
$202K Sell
2,716
-45,181
-94% -$3.36M ﹤0.01% 2407
2020
Q4
$8.17M Buy
47,897
+7,924
+20% +$1.35M 0.01% 829
2020
Q3
$5.61M Buy
39,973
+2,629
+7% +$369K 0.01% 886
2020
Q2
$5.99M Sell
37,344
-10,067
-21% -$1.61M 0.01% 892
2020
Q1
$4.64M Sell
47,411
-611
-1% -$59.8K 0.01% 953
2019
Q4
$6.2M Buy
48,022
+12,065
+34% +$1.56M 0.01% 1040
2019
Q3
$2.7M Buy
35,957
+32,042
+818% +$2.41M ﹤0.01% 1425
2019
Q2
$595K Sell
3,915
-24,033
-86% -$3.65M ﹤0.01% 2033
2019
Q1
$3.33M Buy
27,948
+24,194
+644% +$2.88M 0.01% 1334
2018
Q4
$409K Buy
3,754
+84
+2% +$9.15K ﹤0.01% 2052
2018
Q3
$593K Buy
3,670
+110
+3% +$17.8K ﹤0.01% 2005
2018
Q2
$471K Sell
3,560
-49,655
-93% -$6.57M ﹤0.01% 2065
2018
Q1
$3.94M Buy
53,215
+47,500
+831% +$3.52M 0.01% 1264
2017
Q4
$318K Sell
5,715
-140
-2% -$7.79K ﹤0.01% 2127
2017
Q3
$266K Buy
+5,855
New +$266K ﹤0.01% 2187
2016
Q4
Sell
-6,390
Closed -$393K 2377
2016
Q3
$393K Buy
+6,390
New +$393K ﹤0.01% 2063
2014
Q3
Sell
-7,600
Closed -$226K 2299
2014
Q2
$226K Buy
+7,600
New +$226K ﹤0.01% 2260